Global Adult Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Adult Vaccines market size was valued at US$ million in 2022. With growing demand in downstream market, the Adult Vaccines is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Adult Vaccines market. Adult Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Adult Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Adult Vaccines market.
Key Features:
The report on Adult Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Adult Vaccines market. It may include historical data, market segmentation by Type (e.g., Monovalent Vaccines, Multivalent Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Adult Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Adult Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Adult Vaccines industry. This include advancements in Adult Vaccines technology, Adult Vaccines new entrants, Adult Vaccines new investment, and other innovations that are shaping the future of Adult Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Adult Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Adult Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Adult Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Adult Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Adult Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Adult Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Adult Vaccines market.
Market Segmentation:
Adult Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Adult Vaccines market?
What factors are driving Adult Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adult Vaccines market opportunities vary by end market size?
How does Adult Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Adult Vaccines market size was valued at US$ million in 2022. With growing demand in downstream market, the Adult Vaccines is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Adult Vaccines market. Adult Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Adult Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Adult Vaccines market.
Key Features:
The report on Adult Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Adult Vaccines market. It may include historical data, market segmentation by Type (e.g., Monovalent Vaccines, Multivalent Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Adult Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Adult Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Adult Vaccines industry. This include advancements in Adult Vaccines technology, Adult Vaccines new entrants, Adult Vaccines new investment, and other innovations that are shaping the future of Adult Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Adult Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Adult Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Adult Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Adult Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Adult Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Adult Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Adult Vaccines market.
Market Segmentation:
Adult Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Monovalent Vaccines
- Multivalent Vaccines
- Private Healthcare Firms
- Government Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Solvay Pharmaceuticals
- Moderna
- BioCSL (Seqirus)
- Aventis Pasteur
- Sanofi Pasteur
- Pfizer Inc.
- Merck & Co. Inc.
- GlaxoSmithKline Plc
- Novartis AG
- Johnson & Johnson
- BioNTech
- Bharat Biotech International Limited
- Zhifei
- Wyeth Vaccines
- AstraZeneca Plc
- Medimmune
- Sinovac
- Baxter International Healthcare Company
- Chiron Vaccines
- Serum Institute of India.
What is the 10-year outlook for the global Adult Vaccines market?
What factors are driving Adult Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adult Vaccines market opportunities vary by end market size?
How does Adult Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adult Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Adult Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Adult Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Adult Vaccines Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Multivalent Vaccines
2.3 Adult Vaccines Sales by Type
2.3.1 Global Adult Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Adult Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Adult Vaccines Sale Price by Type (2018-2023)
2.4 Adult Vaccines Segment by Application
2.4.1 Private Healthcare Firms
2.4.2 Government Hospitals
2.5 Adult Vaccines Sales by Application
2.5.1 Global Adult Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Adult Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Adult Vaccines Sale Price by Application (2018-2023)
3 GLOBAL ADULT VACCINES BY COMPANY
3.1 Global Adult Vaccines Breakdown Data by Company
3.1.1 Global Adult Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Adult Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Adult Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Adult Vaccines Revenue by Company (2018-2023)
3.2.2 Global Adult Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Adult Vaccines Sale Price by Company
3.4 Key Manufacturers Adult Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adult Vaccines Product Location Distribution
3.4.2 Players Adult Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ADULT VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Adult Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Adult Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Adult Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Adult Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Adult Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Adult Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Adult Vaccines Sales Growth
4.4 APAC Adult Vaccines Sales Growth
4.5 Europe Adult Vaccines Sales Growth
4.6 Middle East & Africa Adult Vaccines Sales Growth
5 AMERICAS
5.1 Americas Adult Vaccines Sales by Country
5.1.1 Americas Adult Vaccines Sales by Country (2018-2023)
5.1.2 Americas Adult Vaccines Revenue by Country (2018-2023)
5.2 Americas Adult Vaccines Sales by Type
5.3 Americas Adult Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adult Vaccines Sales by Region
6.1.1 APAC Adult Vaccines Sales by Region (2018-2023)
6.1.2 APAC Adult Vaccines Revenue by Region (2018-2023)
6.2 APAC Adult Vaccines Sales by Type
6.3 APAC Adult Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Adult Vaccines by Country
7.1.1 Europe Adult Vaccines Sales by Country (2018-2023)
7.1.2 Europe Adult Vaccines Revenue by Country (2018-2023)
7.2 Europe Adult Vaccines Sales by Type
7.3 Europe Adult Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adult Vaccines by Country
8.1.1 Middle East & Africa Adult Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Adult Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Adult Vaccines Sales by Type
8.3 Middle East & Africa Adult Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adult Vaccines
10.3 Manufacturing Process Analysis of Adult Vaccines
10.4 Industry Chain Structure of Adult Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adult Vaccines Distributors
11.3 Adult Vaccines Customer
12 WORLD FORECAST REVIEW FOR ADULT VACCINES BY GEOGRAPHIC REGION
12.1 Global Adult Vaccines Market Size Forecast by Region
12.1.1 Global Adult Vaccines Forecast by Region (2024-2029)
12.1.2 Global Adult Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Adult Vaccines Forecast by Type
12.7 Global Adult Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Solvay Pharmaceuticals
13.1.1 Solvay Pharmaceuticals Company Information
13.1.2 Solvay Pharmaceuticals Adult Vaccines Product Portfolios and Specifications
13.1.3 Solvay Pharmaceuticals Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Solvay Pharmaceuticals Main Business Overview
13.1.5 Solvay Pharmaceuticals Latest Developments
13.2 Moderna
13.2.1 Moderna Company Information
13.2.2 Moderna Adult Vaccines Product Portfolios and Specifications
13.2.3 Moderna Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Moderna Main Business Overview
13.2.5 Moderna Latest Developments
13.3 BioCSL (Seqirus)
13.3.1 BioCSL (Seqirus) Company Information
13.3.2 BioCSL (Seqirus) Adult Vaccines Product Portfolios and Specifications
13.3.3 BioCSL (Seqirus) Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BioCSL (Seqirus) Main Business Overview
13.3.5 BioCSL (Seqirus) Latest Developments
13.4 Aventis Pasteur
13.4.1 Aventis Pasteur Company Information
13.4.2 Aventis Pasteur Adult Vaccines Product Portfolios and Specifications
13.4.3 Aventis Pasteur Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aventis Pasteur Main Business Overview
13.4.5 Aventis Pasteur Latest Developments
13.5 Sanofi Pasteur
13.5.1 Sanofi Pasteur Company Information
13.5.2 Sanofi Pasteur Adult Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Pasteur Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Pasteur Main Business Overview
13.5.5 Sanofi Pasteur Latest Developments
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Information
13.6.2 Pfizer Inc. Adult Vaccines Product Portfolios and Specifications
13.6.3 Pfizer Inc. Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Inc. Main Business Overview
13.6.5 Pfizer Inc. Latest Developments
13.7 Merck & Co. Inc.
13.7.1 Merck & Co. Inc. Company Information
13.7.2 Merck & Co. Inc. Adult Vaccines Product Portfolios and Specifications
13.7.3 Merck & Co. Inc. Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Merck & Co. Inc. Main Business Overview
13.7.5 Merck & Co. Inc. Latest Developments
13.8 GlaxoSmithKline Plc
13.8.1 GlaxoSmithKline Plc Company Information
13.8.2 GlaxoSmithKline Plc Adult Vaccines Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Plc Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GlaxoSmithKline Plc Main Business Overview
13.8.5 GlaxoSmithKline Plc Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Adult Vaccines Product Portfolios and Specifications
13.9.3 Novartis AG Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson Adult Vaccines Product Portfolios and Specifications
13.10.3 Johnson & Johnson Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 BioNTech
13.11.1 BioNTech Company Information
13.11.2 BioNTech Adult Vaccines Product Portfolios and Specifications
13.11.3 BioNTech Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 BioNTech Main Business Overview
13.11.5 BioNTech Latest Developments
13.12 Bharat Biotech International Limited
13.12.1 Bharat Biotech International Limited Company Information
13.12.2 Bharat Biotech International Limited Adult Vaccines Product Portfolios and Specifications
13.12.3 Bharat Biotech International Limited Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Bharat Biotech International Limited Main Business Overview
13.12.5 Bharat Biotech International Limited Latest Developments
13.13 Zhifei
13.13.1 Zhifei Company Information
13.13.2 Zhifei Adult Vaccines Product Portfolios and Specifications
13.13.3 Zhifei Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Zhifei Main Business Overview
13.13.5 Zhifei Latest Developments
13.14 Wyeth Vaccines
13.14.1 Wyeth Vaccines Company Information
13.14.2 Wyeth Vaccines Adult Vaccines Product Portfolios and Specifications
13.14.3 Wyeth Vaccines Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Wyeth Vaccines Main Business Overview
13.14.5 Wyeth Vaccines Latest Developments
13.15 AstraZeneca Plc
13.15.1 AstraZeneca Plc Company Information
13.15.2 AstraZeneca Plc Adult Vaccines Product Portfolios and Specifications
13.15.3 AstraZeneca Plc Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 AstraZeneca Plc Main Business Overview
13.15.5 AstraZeneca Plc Latest Developments
13.16 Medimmune
13.16.1 Medimmune Company Information
13.16.2 Medimmune Adult Vaccines Product Portfolios and Specifications
13.16.3 Medimmune Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Medimmune Main Business Overview
13.16.5 Medimmune Latest Developments
13.17 Sinovac
13.17.1 Sinovac Company Information
13.17.2 Sinovac Adult Vaccines Product Portfolios and Specifications
13.17.3 Sinovac Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Sinovac Main Business Overview
13.17.5 Sinovac Latest Developments
13.18 Baxter International Healthcare Company
13.18.1 Baxter International Healthcare Company Company Information
13.18.2 Baxter International Healthcare Company Adult Vaccines Product Portfolios and Specifications
13.18.3 Baxter International Healthcare Company Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Baxter International Healthcare Company Main Business Overview
13.18.5 Baxter International Healthcare Company Latest Developments
13.19 Chiron Vaccines
13.19.1 Chiron Vaccines Company Information
13.19.2 Chiron Vaccines Adult Vaccines Product Portfolios and Specifications
13.19.3 Chiron Vaccines Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Chiron Vaccines Main Business Overview
13.19.5 Chiron Vaccines Latest Developments
13.20 Serum Institute of India.
13.20.1 Serum Institute of India. Company Information
13.20.2 Serum Institute of India. Adult Vaccines Product Portfolios and Specifications
13.20.3 Serum Institute of India. Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Serum Institute of India. Main Business Overview
13.20.5 Serum Institute of India. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adult Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Adult Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Adult Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Adult Vaccines Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Multivalent Vaccines
2.3 Adult Vaccines Sales by Type
2.3.1 Global Adult Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Adult Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Adult Vaccines Sale Price by Type (2018-2023)
2.4 Adult Vaccines Segment by Application
2.4.1 Private Healthcare Firms
2.4.2 Government Hospitals
2.5 Adult Vaccines Sales by Application
2.5.1 Global Adult Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Adult Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Adult Vaccines Sale Price by Application (2018-2023)
3 GLOBAL ADULT VACCINES BY COMPANY
3.1 Global Adult Vaccines Breakdown Data by Company
3.1.1 Global Adult Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Adult Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Adult Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Adult Vaccines Revenue by Company (2018-2023)
3.2.2 Global Adult Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Adult Vaccines Sale Price by Company
3.4 Key Manufacturers Adult Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adult Vaccines Product Location Distribution
3.4.2 Players Adult Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ADULT VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Adult Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Adult Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Adult Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Adult Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Adult Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Adult Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Adult Vaccines Sales Growth
4.4 APAC Adult Vaccines Sales Growth
4.5 Europe Adult Vaccines Sales Growth
4.6 Middle East & Africa Adult Vaccines Sales Growth
5 AMERICAS
5.1 Americas Adult Vaccines Sales by Country
5.1.1 Americas Adult Vaccines Sales by Country (2018-2023)
5.1.2 Americas Adult Vaccines Revenue by Country (2018-2023)
5.2 Americas Adult Vaccines Sales by Type
5.3 Americas Adult Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adult Vaccines Sales by Region
6.1.1 APAC Adult Vaccines Sales by Region (2018-2023)
6.1.2 APAC Adult Vaccines Revenue by Region (2018-2023)
6.2 APAC Adult Vaccines Sales by Type
6.3 APAC Adult Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Adult Vaccines by Country
7.1.1 Europe Adult Vaccines Sales by Country (2018-2023)
7.1.2 Europe Adult Vaccines Revenue by Country (2018-2023)
7.2 Europe Adult Vaccines Sales by Type
7.3 Europe Adult Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adult Vaccines by Country
8.1.1 Middle East & Africa Adult Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Adult Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Adult Vaccines Sales by Type
8.3 Middle East & Africa Adult Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adult Vaccines
10.3 Manufacturing Process Analysis of Adult Vaccines
10.4 Industry Chain Structure of Adult Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adult Vaccines Distributors
11.3 Adult Vaccines Customer
12 WORLD FORECAST REVIEW FOR ADULT VACCINES BY GEOGRAPHIC REGION
12.1 Global Adult Vaccines Market Size Forecast by Region
12.1.1 Global Adult Vaccines Forecast by Region (2024-2029)
12.1.2 Global Adult Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Adult Vaccines Forecast by Type
12.7 Global Adult Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Solvay Pharmaceuticals
13.1.1 Solvay Pharmaceuticals Company Information
13.1.2 Solvay Pharmaceuticals Adult Vaccines Product Portfolios and Specifications
13.1.3 Solvay Pharmaceuticals Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Solvay Pharmaceuticals Main Business Overview
13.1.5 Solvay Pharmaceuticals Latest Developments
13.2 Moderna
13.2.1 Moderna Company Information
13.2.2 Moderna Adult Vaccines Product Portfolios and Specifications
13.2.3 Moderna Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Moderna Main Business Overview
13.2.5 Moderna Latest Developments
13.3 BioCSL (Seqirus)
13.3.1 BioCSL (Seqirus) Company Information
13.3.2 BioCSL (Seqirus) Adult Vaccines Product Portfolios and Specifications
13.3.3 BioCSL (Seqirus) Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BioCSL (Seqirus) Main Business Overview
13.3.5 BioCSL (Seqirus) Latest Developments
13.4 Aventis Pasteur
13.4.1 Aventis Pasteur Company Information
13.4.2 Aventis Pasteur Adult Vaccines Product Portfolios and Specifications
13.4.3 Aventis Pasteur Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aventis Pasteur Main Business Overview
13.4.5 Aventis Pasteur Latest Developments
13.5 Sanofi Pasteur
13.5.1 Sanofi Pasteur Company Information
13.5.2 Sanofi Pasteur Adult Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Pasteur Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Pasteur Main Business Overview
13.5.5 Sanofi Pasteur Latest Developments
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Information
13.6.2 Pfizer Inc. Adult Vaccines Product Portfolios and Specifications
13.6.3 Pfizer Inc. Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Inc. Main Business Overview
13.6.5 Pfizer Inc. Latest Developments
13.7 Merck & Co. Inc.
13.7.1 Merck & Co. Inc. Company Information
13.7.2 Merck & Co. Inc. Adult Vaccines Product Portfolios and Specifications
13.7.3 Merck & Co. Inc. Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Merck & Co. Inc. Main Business Overview
13.7.5 Merck & Co. Inc. Latest Developments
13.8 GlaxoSmithKline Plc
13.8.1 GlaxoSmithKline Plc Company Information
13.8.2 GlaxoSmithKline Plc Adult Vaccines Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Plc Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GlaxoSmithKline Plc Main Business Overview
13.8.5 GlaxoSmithKline Plc Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Adult Vaccines Product Portfolios and Specifications
13.9.3 Novartis AG Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson Adult Vaccines Product Portfolios and Specifications
13.10.3 Johnson & Johnson Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 BioNTech
13.11.1 BioNTech Company Information
13.11.2 BioNTech Adult Vaccines Product Portfolios and Specifications
13.11.3 BioNTech Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 BioNTech Main Business Overview
13.11.5 BioNTech Latest Developments
13.12 Bharat Biotech International Limited
13.12.1 Bharat Biotech International Limited Company Information
13.12.2 Bharat Biotech International Limited Adult Vaccines Product Portfolios and Specifications
13.12.3 Bharat Biotech International Limited Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Bharat Biotech International Limited Main Business Overview
13.12.5 Bharat Biotech International Limited Latest Developments
13.13 Zhifei
13.13.1 Zhifei Company Information
13.13.2 Zhifei Adult Vaccines Product Portfolios and Specifications
13.13.3 Zhifei Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Zhifei Main Business Overview
13.13.5 Zhifei Latest Developments
13.14 Wyeth Vaccines
13.14.1 Wyeth Vaccines Company Information
13.14.2 Wyeth Vaccines Adult Vaccines Product Portfolios and Specifications
13.14.3 Wyeth Vaccines Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Wyeth Vaccines Main Business Overview
13.14.5 Wyeth Vaccines Latest Developments
13.15 AstraZeneca Plc
13.15.1 AstraZeneca Plc Company Information
13.15.2 AstraZeneca Plc Adult Vaccines Product Portfolios and Specifications
13.15.3 AstraZeneca Plc Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 AstraZeneca Plc Main Business Overview
13.15.5 AstraZeneca Plc Latest Developments
13.16 Medimmune
13.16.1 Medimmune Company Information
13.16.2 Medimmune Adult Vaccines Product Portfolios and Specifications
13.16.3 Medimmune Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Medimmune Main Business Overview
13.16.5 Medimmune Latest Developments
13.17 Sinovac
13.17.1 Sinovac Company Information
13.17.2 Sinovac Adult Vaccines Product Portfolios and Specifications
13.17.3 Sinovac Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Sinovac Main Business Overview
13.17.5 Sinovac Latest Developments
13.18 Baxter International Healthcare Company
13.18.1 Baxter International Healthcare Company Company Information
13.18.2 Baxter International Healthcare Company Adult Vaccines Product Portfolios and Specifications
13.18.3 Baxter International Healthcare Company Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Baxter International Healthcare Company Main Business Overview
13.18.5 Baxter International Healthcare Company Latest Developments
13.19 Chiron Vaccines
13.19.1 Chiron Vaccines Company Information
13.19.2 Chiron Vaccines Adult Vaccines Product Portfolios and Specifications
13.19.3 Chiron Vaccines Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Chiron Vaccines Main Business Overview
13.19.5 Chiron Vaccines Latest Developments
13.20 Serum Institute of India.
13.20.1 Serum Institute of India. Company Information
13.20.2 Serum Institute of India. Adult Vaccines Product Portfolios and Specifications
13.20.3 Serum Institute of India. Adult Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Serum Institute of India. Main Business Overview
13.20.5 Serum Institute of India. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adult Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Adult Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Multivalent Vaccines
Table 5. Global Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Adult Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Adult Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Adult Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Adult Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Adult Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Adult Vaccines Revenue by Application (2018-2023)
Table 13. Global Adult Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Adult Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Adult Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Adult Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Adult Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Adult Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Adult Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Adult Vaccines Producing Area Distribution and Sales Area
Table 21. Players Adult Vaccines Products Offered
Table 22. Adult Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Adult Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Adult Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Adult Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Adult Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Adult Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Adult Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Adult Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Adult Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Adult Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Adult Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Adult Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Adult Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Adult Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Adult Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Adult Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Adult Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Adult Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Adult Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Adult Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Adult Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Adult Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Adult Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Adult Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Adult Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Adult Vaccines
Table 58. Key Market Challenges & Risks of Adult Vaccines
Table 59. Key Industry Trends of Adult Vaccines
Table 60. Adult Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Adult Vaccines Distributors List
Table 63. Adult Vaccines Customer List
Table 64. Global Adult Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Adult Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Adult Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Adult Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Adult Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Adult Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Adult Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Adult Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Adult Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Adult Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Adult Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Adult Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Adult Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Adult Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Solvay Pharmaceuticals Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Solvay Pharmaceuticals Adult Vaccines Product Portfolios and Specifications
Table 80. Solvay Pharmaceuticals Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Solvay Pharmaceuticals Main Business
Table 82. Solvay Pharmaceuticals Latest Developments
Table 83. Moderna Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Moderna Adult Vaccines Product Portfolios and Specifications
Table 85. Moderna Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Moderna Main Business
Table 87. Moderna Latest Developments
Table 88. BioCSL (Seqirus) Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. BioCSL (Seqirus) Adult Vaccines Product Portfolios and Specifications
Table 90. BioCSL (Seqirus) Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. BioCSL (Seqirus) Main Business
Table 92. BioCSL (Seqirus) Latest Developments
Table 93. Aventis Pasteur Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Aventis Pasteur Adult Vaccines Product Portfolios and Specifications
Table 95. Aventis Pasteur Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Aventis Pasteur Main Business
Table 97. Aventis Pasteur Latest Developments
Table 98. Sanofi Pasteur Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur Adult Vaccines Product Portfolios and Specifications
Table 100. Sanofi Pasteur Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Pasteur Main Business
Table 102. Sanofi Pasteur Latest Developments
Table 103. Pfizer Inc. Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Inc. Adult Vaccines Product Portfolios and Specifications
Table 105. Pfizer Inc. Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Inc. Main Business
Table 107. Pfizer Inc. Latest Developments
Table 108. Merck & Co. Inc. Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck & Co. Inc. Adult Vaccines Product Portfolios and Specifications
Table 110. Merck & Co. Inc. Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Merck & Co. Inc. Main Business
Table 112. Merck & Co. Inc. Latest Developments
Table 113. GlaxoSmithKline Plc Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Plc Adult Vaccines Product Portfolios and Specifications
Table 115. GlaxoSmithKline Plc Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. GlaxoSmithKline Plc Main Business
Table 117. GlaxoSmithKline Plc Latest Developments
Table 118. Novartis AG Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG Adult Vaccines Product Portfolios and Specifications
Table 120. Novartis AG Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. Johnson & Johnson Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Johnson & Johnson Adult Vaccines Product Portfolios and Specifications
Table 125. Johnson & Johnson Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Latest Developments
Table 128. BioNTech Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. BioNTech Adult Vaccines Product Portfolios and Specifications
Table 130. BioNTech Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. BioNTech Main Business
Table 132. BioNTech Latest Developments
Table 133. Bharat Biotech International Limited Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Bharat Biotech International Limited Adult Vaccines Product Portfolios and Specifications
Table 135. Bharat Biotech International Limited Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Bharat Biotech International Limited Main Business
Table 137. Bharat Biotech International Limited Latest Developments
Table 138. Zhifei Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhifei Adult Vaccines Product Portfolios and Specifications
Table 140. Zhifei Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Zhifei Main Business
Table 142. Zhifei Latest Developments
Table 143. Wyeth Vaccines Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Wyeth Vaccines Adult Vaccines Product Portfolios and Specifications
Table 145. Wyeth Vaccines Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Wyeth Vaccines Main Business
Table 147. Wyeth Vaccines Latest Developments
Table 148. AstraZeneca Plc Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. AstraZeneca Plc Adult Vaccines Product Portfolios and Specifications
Table 150. AstraZeneca Plc Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. AstraZeneca Plc Main Business
Table 152. AstraZeneca Plc Latest Developments
Table 153. Medimmune Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Medimmune Adult Vaccines Product Portfolios and Specifications
Table 155. Medimmune Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Medimmune Main Business
Table 157. Medimmune Latest Developments
Table 158. Sinovac Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Sinovac Adult Vaccines Product Portfolios and Specifications
Table 160. Sinovac Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Sinovac Main Business
Table 162. Sinovac Latest Developments
Table 163. Baxter International Healthcare Company Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Baxter International Healthcare Company Adult Vaccines Product Portfolios and Specifications
Table 165. Baxter International Healthcare Company Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Baxter International Healthcare Company Main Business
Table 167. Baxter International Healthcare Company Latest Developments
Table 168. Chiron Vaccines Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Chiron Vaccines Adult Vaccines Product Portfolios and Specifications
Table 170. Chiron Vaccines Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Chiron Vaccines Main Business
Table 172. Chiron Vaccines Latest Developments
Table 173. Serum Institute of India. Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Serum Institute of India. Adult Vaccines Product Portfolios and Specifications
Table 175. Serum Institute of India. Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Serum Institute of India. Main Business
Table 177. Serum Institute of India. Latest Developments
Table 1. Adult Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Adult Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Multivalent Vaccines
Table 5. Global Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Adult Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Adult Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Adult Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Adult Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Adult Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Adult Vaccines Revenue by Application (2018-2023)
Table 13. Global Adult Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Adult Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Adult Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Adult Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Adult Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Adult Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Adult Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Adult Vaccines Producing Area Distribution and Sales Area
Table 21. Players Adult Vaccines Products Offered
Table 22. Adult Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Adult Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Adult Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Adult Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Adult Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Adult Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Adult Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Adult Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Adult Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Adult Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Adult Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Adult Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Adult Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Adult Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Adult Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Adult Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Adult Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Adult Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Adult Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Adult Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Adult Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Adult Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Adult Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Adult Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Adult Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Adult Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Adult Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Adult Vaccines
Table 58. Key Market Challenges & Risks of Adult Vaccines
Table 59. Key Industry Trends of Adult Vaccines
Table 60. Adult Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Adult Vaccines Distributors List
Table 63. Adult Vaccines Customer List
Table 64. Global Adult Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Adult Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Adult Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Adult Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Adult Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Adult Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Adult Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Adult Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Adult Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Adult Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Adult Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Adult Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Adult Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Adult Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Solvay Pharmaceuticals Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Solvay Pharmaceuticals Adult Vaccines Product Portfolios and Specifications
Table 80. Solvay Pharmaceuticals Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Solvay Pharmaceuticals Main Business
Table 82. Solvay Pharmaceuticals Latest Developments
Table 83. Moderna Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Moderna Adult Vaccines Product Portfolios and Specifications
Table 85. Moderna Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Moderna Main Business
Table 87. Moderna Latest Developments
Table 88. BioCSL (Seqirus) Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. BioCSL (Seqirus) Adult Vaccines Product Portfolios and Specifications
Table 90. BioCSL (Seqirus) Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. BioCSL (Seqirus) Main Business
Table 92. BioCSL (Seqirus) Latest Developments
Table 93. Aventis Pasteur Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Aventis Pasteur Adult Vaccines Product Portfolios and Specifications
Table 95. Aventis Pasteur Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Aventis Pasteur Main Business
Table 97. Aventis Pasteur Latest Developments
Table 98. Sanofi Pasteur Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur Adult Vaccines Product Portfolios and Specifications
Table 100. Sanofi Pasteur Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Pasteur Main Business
Table 102. Sanofi Pasteur Latest Developments
Table 103. Pfizer Inc. Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Inc. Adult Vaccines Product Portfolios and Specifications
Table 105. Pfizer Inc. Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Inc. Main Business
Table 107. Pfizer Inc. Latest Developments
Table 108. Merck & Co. Inc. Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck & Co. Inc. Adult Vaccines Product Portfolios and Specifications
Table 110. Merck & Co. Inc. Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Merck & Co. Inc. Main Business
Table 112. Merck & Co. Inc. Latest Developments
Table 113. GlaxoSmithKline Plc Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Plc Adult Vaccines Product Portfolios and Specifications
Table 115. GlaxoSmithKline Plc Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. GlaxoSmithKline Plc Main Business
Table 117. GlaxoSmithKline Plc Latest Developments
Table 118. Novartis AG Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG Adult Vaccines Product Portfolios and Specifications
Table 120. Novartis AG Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. Johnson & Johnson Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Johnson & Johnson Adult Vaccines Product Portfolios and Specifications
Table 125. Johnson & Johnson Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Latest Developments
Table 128. BioNTech Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. BioNTech Adult Vaccines Product Portfolios and Specifications
Table 130. BioNTech Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. BioNTech Main Business
Table 132. BioNTech Latest Developments
Table 133. Bharat Biotech International Limited Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Bharat Biotech International Limited Adult Vaccines Product Portfolios and Specifications
Table 135. Bharat Biotech International Limited Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Bharat Biotech International Limited Main Business
Table 137. Bharat Biotech International Limited Latest Developments
Table 138. Zhifei Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhifei Adult Vaccines Product Portfolios and Specifications
Table 140. Zhifei Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Zhifei Main Business
Table 142. Zhifei Latest Developments
Table 143. Wyeth Vaccines Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Wyeth Vaccines Adult Vaccines Product Portfolios and Specifications
Table 145. Wyeth Vaccines Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Wyeth Vaccines Main Business
Table 147. Wyeth Vaccines Latest Developments
Table 148. AstraZeneca Plc Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. AstraZeneca Plc Adult Vaccines Product Portfolios and Specifications
Table 150. AstraZeneca Plc Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. AstraZeneca Plc Main Business
Table 152. AstraZeneca Plc Latest Developments
Table 153. Medimmune Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Medimmune Adult Vaccines Product Portfolios and Specifications
Table 155. Medimmune Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Medimmune Main Business
Table 157. Medimmune Latest Developments
Table 158. Sinovac Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Sinovac Adult Vaccines Product Portfolios and Specifications
Table 160. Sinovac Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Sinovac Main Business
Table 162. Sinovac Latest Developments
Table 163. Baxter International Healthcare Company Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Baxter International Healthcare Company Adult Vaccines Product Portfolios and Specifications
Table 165. Baxter International Healthcare Company Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Baxter International Healthcare Company Main Business
Table 167. Baxter International Healthcare Company Latest Developments
Table 168. Chiron Vaccines Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Chiron Vaccines Adult Vaccines Product Portfolios and Specifications
Table 170. Chiron Vaccines Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Chiron Vaccines Main Business
Table 172. Chiron Vaccines Latest Developments
Table 173. Serum Institute of India. Basic Information, Adult Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Serum Institute of India. Adult Vaccines Product Portfolios and Specifications
Table 175. Serum Institute of India. Adult Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Serum Institute of India. Main Business
Table 177. Serum Institute of India. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Adult Vaccines
Figure 2. Adult Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Adult Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Adult Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Adult Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Vaccines
Figure 10. Product Picture of Multivalent Vaccines
Figure 11. Global Adult Vaccines Sales Market Share by Type in 2022
Figure 12. Global Adult Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Adult Vaccines Consumed in Private Healthcare Firms
Figure 14. Global Adult Vaccines Market: Private Healthcare Firms (2018-2023) & (K Units)
Figure 15. Adult Vaccines Consumed in Government Hospitals
Figure 16. Global Adult Vaccines Market: Government Hospitals (2018-2023) & (K Units)
Figure 17. Global Adult Vaccines Sales Market Share by Application (2022)
Figure 18. Global Adult Vaccines Revenue Market Share by Application in 2022
Figure 19. Adult Vaccines Sales Market by Company in 2022 (K Units)
Figure 20. Global Adult Vaccines Sales Market Share by Company in 2022
Figure 21. Adult Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Adult Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Adult Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Adult Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Adult Vaccines Sales 2018-2023 (K Units)
Figure 26. Americas Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Adult Vaccines Sales 2018-2023 (K Units)
Figure 28. APAC Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Adult Vaccines Sales 2018-2023 (K Units)
Figure 30. Europe Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Adult Vaccines Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Adult Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Adult Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Adult Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Adult Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Adult Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Adult Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Adult Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Adult Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Adult Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Adult Vaccines
Figure 72. Industry Chain Structure of Adult Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Adult Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Adult Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Adult Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Adult Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Adult Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Adult Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Adult Vaccines
Figure 2. Adult Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Adult Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Adult Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Adult Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Vaccines
Figure 10. Product Picture of Multivalent Vaccines
Figure 11. Global Adult Vaccines Sales Market Share by Type in 2022
Figure 12. Global Adult Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Adult Vaccines Consumed in Private Healthcare Firms
Figure 14. Global Adult Vaccines Market: Private Healthcare Firms (2018-2023) & (K Units)
Figure 15. Adult Vaccines Consumed in Government Hospitals
Figure 16. Global Adult Vaccines Market: Government Hospitals (2018-2023) & (K Units)
Figure 17. Global Adult Vaccines Sales Market Share by Application (2022)
Figure 18. Global Adult Vaccines Revenue Market Share by Application in 2022
Figure 19. Adult Vaccines Sales Market by Company in 2022 (K Units)
Figure 20. Global Adult Vaccines Sales Market Share by Company in 2022
Figure 21. Adult Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Adult Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Adult Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Adult Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Adult Vaccines Sales 2018-2023 (K Units)
Figure 26. Americas Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Adult Vaccines Sales 2018-2023 (K Units)
Figure 28. APAC Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Adult Vaccines Sales 2018-2023 (K Units)
Figure 30. Europe Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Adult Vaccines Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Adult Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Adult Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Adult Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Adult Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Adult Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Adult Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Adult Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Adult Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Adult Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Adult Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Adult Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Adult Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Adult Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Adult Vaccines
Figure 72. Industry Chain Structure of Adult Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Adult Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Adult Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Adult Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Adult Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Adult Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Adult Vaccines Revenue Market Share Forecast by Application (2024-2029)
